Profusa, Inc. Files Definitive Additional Materials
Ticker: NVACW · Form: DEFA14A · Filed: Oct 7, 2025 · CIK: 1859807
| Field | Detail |
|---|---|
| Company | Profusa, INC. (NVACW) |
| Form Type | DEFA14A |
| Filed Date | Oct 7, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, additional-materials, corporate-governance
TL;DR
Profusa (formerly NorthView) dropped more shareholder docs, check 'em.
AI Summary
Profusa, Inc. filed a Definitive Additional Materials (DEFA14A) on October 7, 2025, related to its proxy statement. This filing concerns materials provided to shareholders, likely in relation to upcoming corporate actions or meetings. Profusa, Inc. was formerly known as NorthView Acquisition Corp until April 29, 2021.
Why It Matters
This filing indicates that Profusa, Inc. is providing supplementary information to its shareholders, which could be crucial for understanding upcoming shareholder votes or corporate decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of additional proxy materials and does not inherently present new financial risks.
Key Players & Entities
- Profusa, Inc. (company) — Registrant
- NorthView Acquisition Corp (company) — Former company name
- 20210429 (date) — Date of name change
- 20251007 (date) — Filing date
FAQ
What type of filing is this DEFA14A for Profusa, Inc.?
This filing is for Definitive Additional Materials, as indicated by the form type DEFA14A and the checkbox selection.
When was Profusa, Inc. formerly known as NorthView Acquisition Corp?
Profusa, Inc. was formerly known as NorthView Acquisition Corp until April 29, 2021.
What is the filing date of this DEFA14A?
The filing date is October 7, 2025.
What is the primary business address of Profusa, Inc.?
The business address is 207 WEST 25TH ST, 9TH FLOOR, NEW YORK, NY 10001.
Under which section of the Securities Exchange Act of 1934 is this filing made?
This filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Filing Stats: 1,039 words · 4 min read · ~3 pages · Grade level 13.8 · Accepted 2025-10-07 16:30:26
Filing Documents
- ea0260572-defa14a_profusa.htm (DEFA14A) — 20KB
- image_001.jpg (GRAPHIC) — 11KB
- 0001213900-25-097058.txt ( ) — 37KB
From the Filing
ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 PROFUSA, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. PROFUSA, INC. 626 Bancroft Way Suite A Berkeley, CA 94710 Dear Stockholder: As you are aware, the Board of Directors of Profusa, Inc. (the “Company,” “we,” or “our”) called a Special Meeting of Stockholders (the “Special Meeting”) on October 7, 2025 at 10:00 A.M. Eastern Time, or at any adjournment or postponement thereof. On date of the Special Meeting, the meeting was convened, and adjourned, without conducting any business because the Company did not have a sufficient number of shares of the Company’s common stock present in person or represented by proxy at the Special Meeting to constitute a quorum. The adjourned Special Meeting will reconvene on Monday, October 20, 2025 at 10:00 a.m. Eastern Time. The information in this letter is intended to supplement and amend certain information included in the definitive proxy statement relating to the Special Meeting, which was filed with the Securities and Exchange Commission on September 23, 2025 (the “Proxy Statement”). Quorum Requirement The purpose of this letter is to provide new information about the quorum requirement for the Special Meeting. On October 7, 2025, our Board of Directors adopted resolutions to amend our Bylaws to provide that the holders of 33 and 1/3% of the outstanding shares of Common Stock will constitute a quorum at all meetings of our stockholders for the transaction of business (the “Bylaw Amendment”), including at the Special Meeting. Our Bylaws previously provided that the holders of a majority of the outstanding shares of stock constituted a quorum at all meetings of our stockholders for the transaction of business. By reducing the quorum requirement from a majority of outstanding stock to 33 and 1/3% of outstanding stock, we are more likely to reach quorum and hold a valid stockholders meeting. In particular, our Board of Directors believes that there are important proposals to be considered by stockholders at the Special Meeting including, but not limited to, an increase in authorized shares. If a quorum cannot be obtained, no action can be taken on these matters, and the Company would be obligated to incur the expense of calling and holding another meeting of its stockholders. Moreover, the Board believes that the new quorum requirement is high enough to ensure that a broad range of stockholders are represented at meetings, while also reducing the risk of the Company needing to adjourn such meetings. Supplemental Disclosures to the Proxy Statement The following Q&A from page 3 of the Proxy Q: What constitutes a quorum? A: The holders of one-third of the 40,859,307 shares of Common Stock outstanding as of the Record Date, either present by remote communication or represented by proxy, constitutes a quorum. A quorum is necessary to conduct the Special Meeting. If you sign and return your paper proxy card or authorize a proxy to vote electronically or telephonically, your shares will be counted to determine whether we have a quorum even if you abstain or fail to vote as indicated in the proxy materials. Broker non-votes and abstentions will be counted as present for the purpose of establishing a quorum. If a quorum is not present by attendance at the Special Meeting or represented by proxy, the chairman of the meeting or the stockholders present by attendance at the meeting or by proxy may adjourn the Special Meeting until a quorum is present. If an adjournment is for more than 30 days or a new record date is fixed for the adjourned meeting, we will provide notice of the adjourned meeting to each stockholder of record entitled to vote at the meeting. 1 Impact of the Quorum Change on Voting at the Special Meeting The approval of each of the Proposals requires the affirmative vote of a majority of the votes cast on the matter. As a result of the Bylaw Amendment, fewer outstanding shares of stock will be required to constitute a quorum at the Special Meeting. This means that if the number of shares represented at the Special Meeting satisfies the new qu